AzTrials
AzTrials

DeliriumNCT03470662

Prevention of Delirium Among Elderly Patients With Hip Fractures

A study testing Care bundle in people with Delirium and Hip Fractures, run by Zhoupu Hospital, Pudong New Area, Shanghai, China at 1 site in China.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Objective: To evaluate the effect of care bundle on prevention of delirium among elderly patients with hip fractures. Methods: A prospective randomized case control study was performed for 80 patients (≥65 years) with hip fractures treated surgically according to their ages and the type of fractures from March 1th of… Read more about this study

Who is it for?
Ages 65 years and older
Conditions the study is for
Delirium, Hip Fractures
What is being tested?
Care bundle
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteChina
Study dates
1 Mar 2017to 30 Sep 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 65 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • ≥65 years
  • with hip fractures
  • treated surgically

Who cannot join

  • <65 years
  • psychiatric history
  • ICU post-operation
  • refuse to join this study
  • have delirium pre-operation

Trial locations and contacts

1 site in 1 country.

China1 site
  • Zhoupu Hospital Shanghai

    Shanghai

Other trials in China

About this study

Official title: Effect of Prospective Care Bundle on Prevention of Delirium Among Elderly Patients With Hip Fractures

Objective: To evaluate the effect of care bundle on prevention of delirium among elderly patients with hip fractures.

Methods: A prospective randomized case control study was performed for 80 patients (≥65 years) with hip fractures treated surgically according to their ages and the type of fractures from March 1th of 2017 to June 30th of 2017.There were 11 males and 69 females, with the age of (79.3±7.84) years. Confusion assessment method (CAM) was applied to diagnose delirium after surgery, the subjects were randomized divided into experimental group (n=43) and control group (n=37). The parameters next were recorded and analyzed, including age, gender, type of fractures, type of internal instrument, amount of bleeding, time between injured to surgery, time length of operation, type of operation, VAS, incidence of delirium, perioperative complications and adverse events.

Being tested
Care bundle
Keywords
Hip fractures, Delirium, Aged, Care bundle
Medical subject headings
Delirium, Hip Fractures

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Care bundleOther

    Care bundle

Study groups in NCT03470662
Study groupRoleWhat they receive
experimental groupExperimentalCare bundle
Receives: Other: Care bundle
control groupNo interventionroutine care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. incidence of delirium among elderly patients with hip fractures

    study hypothesis: the incidence of delirium postoperatively in experimental group is lower compared with control group

    Measured: 3 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Mar 2018
  2. Study start1 Mar 2017
  3. Primary completion30 Jun 2017
  4. Study completion30 Sep 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03470662
Sponsor's protocol ID
YuFengbinDelirium
Status last verified
Mar 2018
First submitted
7 Mar 2018
Last updated
20 Mar 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Care bundle in people with Delirium and Hip Fractures, run by Zhoupu Hospital, Pudong New Area, Shanghai, China at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Mar 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

incidence of delirium among elderly patients with hip fractures (time frame: 3 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2018.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in